sec filing
AI
NASDAQ · AIMD
Ainos, Inc.
Healthcare · Biotechnology
$1.42
Down-$0.02 (-1.39%)
Updated Aug 15, 2026, 9:20 AM
SID Score
2.8/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 7.91M
- P/E ratio
- -0.5
- Dividend yield
- 0.00%
- 52-week range
- $1.26 – $4.44
- Volume
- 21.19K
- Avg. volume
- 660.22K
Price performance
AIMD price history
1M range · 21 trading sessions · Daily adjusted prices
AIMD closed at $1.42 after 21 trading sessions, down 13.94% for the selected period.
- Last close
- $1.42
- Period change
- -13.94%
- Period low
- $1.31
- Period high
- $1.65
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Aug 14, 2026 | $1.44 | $1.555 | $1.40 | $1.42 | 21.19K |
| Aug 13, 2026 | $1.495 | $1.51 | $1.42 | $1.44 | 14.39K |
| Aug 12, 2026 | $1.51 | $1.54 | $1.45 | $1.49 | 42.63K |
| Aug 11, 2026 | $1.46 | $1.4999 | $1.45 | $1.48 | 12.04K |
| Aug 10, 2026 | $1.55 | $1.589 | $1.40 | $1.43 | 23.49K |
| Aug 7, 2026 | $1.48 | $1.557 | $1.43 | $1.49 | 34.79K |
| Aug 6, 2026 | $1.37 | $1.59 | $1.37 | $1.53 | 98.93K |
| Aug 5, 2026 | $1.36 | $1.46 | $1.35 | $1.42 | 22.34K |
| Aug 4, 2026 | $1.49 | $1.53 | $1.31 | $1.41 | 199.68K |
| Aug 3, 2026 | $1.36 | $1.48 | $1.33 | $1.45 | 3.42M |
| Jul 31, 2026 | $1.38 | $1.415 | $1.33 | $1.33 | 19.35K |
| Jul 30, 2026 | $1.36 | $1.39 | $1.30 | $1.36 | 17.66K |
| Jul 29, 2026 | $1.30 | $1.4152 | $1.30 | $1.32 | 15.76K |
| Jul 28, 2026 | $1.34 | $1.45 | $1.30 | $1.31 | 17.99K |
| Jul 27, 2026 | $1.42 | $1.455 | $1.32 | $1.33 | 58.76K |
| Jul 24, 2026 | $1.51 | $1.565 | $1.38 | $1.40 | 39.46K |
| Jul 23, 2026 | $1.6157 | $1.6157 | $1.51 | $1.51 | 14.67K |
| Jul 22, 2026 | $1.59 | $1.6201 | $1.523 | $1.54 | 19.45K |
| Jul 21, 2026 | $1.67 | $1.67 | $1.52 | $1.56 | 36.57K |
| Jul 20, 2026 | $1.6125 | $1.6993 | $1.56 | $1.59 | 26.09K |
| Jul 17, 2026 | $1.73 | $1.73 | $1.60 | $1.65 | 68.54K |
Latest AIMD news
The latest Smart Investors Daily articles mentioning AIMD.
Stock researchResearch & News · Analysis
Loading stock research…

